mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.004 |
mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.006 |
mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.006 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.007 |
mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.007 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.007 |
mRNA |
CX-5461 |
GDSC1000 |
pan-cancer |
AAC |
-0.084 |
0.007 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.008 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.16 |
0.009 |